AGEN
AGENUS INC
Company overview
- Market capitalization
- $424.54M
- Employees
- 81
- Latest publication
- 2026-09-29
About AGENUS INC
Agenus Inc., a clinical-stage biotechnology company, discovers and develops immunotherapies for cancer and infectious diseases in the United States and internationally. It offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. The company also develops Balstilimab, a programmed death receptor-1 (PD-1) blocking antibody; AGEN1181, a human Fc-enhanced cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody that is in Phase 2 trials in metastatic colorectal cancer (mCRC), pancreatic cancer, and melanoma; AGEN2373, a CD137 monospecific antibody that is in Phase 1b clinical trial; AGEN1423, a CD73/TGFß TRAP antibody; AGEN1571, an ILT2 monospecific antibody that is in clinical development; and BMS-986442, a TIGIT bispecific antibodies. In addition, it develops INCAGN1876, a GITR agonist; INCAGN2390, a TIM-3 monoclonal antibodies; INCAGN2385, a LAG-3 monospecific antibody; MK-4830, a monospecific antibody targeting ILT4 that is in Phase 2 clinical trial; and AGEN1884. The company operates under the Agenus, MiNK, Prophage, Retrocyte Display, and STIMULON trademarks. It has collaborations with Bristol-Myers Squibb Company, Betta Pharmaceuticals Co., Ltd., UroGen Pharma Ltd., Gilead Sciences, Inc., Incyte Corporation, and Merck Sharp & Dohme. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 33,736,000USD | 34,204,000USD | 30,235,000USD | 25,691,000USD | 24,066,000USD | 26,837,000USD | 25,112,000USD | 23,509,000USD |
| Cost Of Revenue | 583,000USD | 7,511,000USD | 24,238,000USD | 26,953,000USD | 21,659,000USD | 33,893,000USD | 41,204,000USD | 36,886,000USD |
| Gross Profit | 33,153,000USD | 26,693,000USD | 5,997,000USD | -1,262,000USD | 2,407,000USD | -7,056,000USD | -16,092,000USD | -13,377,000USD |
| Research Development | 11,822,000USD | 7,511,000USD | — | 26,710,000USD | 21,522,000USD | 33,775,000USD | 41,058,000USD | 36,771,000USD |
| Selling General Administrative | 6,860,000USD | 12,295,000USD | 10,860,000USD | 15,518,000USD | 15,718,000USD | 20,931,000USD | 17,275,000USD | 16,816,000USD |
| Total Operating Expenses | 18,099,000USD | 12,295,000USD | 10,542,000USD | 15,449,000USD | 15,718,000USD | 18,840,000USD | 15,412,000USD | 16,816,000USD |
| Operating Income | 15,054,000USD | 14,398,000USD | -4,545,000USD | -16,711,000USD | -13,311,000USD | -25,896,000USD | -31,504,000USD | -30,193,000USD |
| Interest Expense | 14,690,000USD | 16,019,000USD | 13,170,000USD | 13,289,000USD | 12,795,000USD | 20,686,000USD | 35,729,000USD | 31,745,000USD |
| Net Interest Income | -14,669,000USD | -16,019,000USD | -13,170,000USD | -13,289,000USD | -12,795,000USD | -20,686,000USD | -35,729,000USD | -31,745,000USD |
| Income Before Tax | 39,206,000USD | -10,612,000USD | 63,911,000USD | -30,012,000USD | -26,370,000USD | -46,806,000USD | -67,214,000USD | -54,797,000USD |
| Net Income | 39,226,000USD | -10,578,000USD | 63,914,000USD | -27,955,000USD | -25,266,000USD | -45,859,000USD | -66,386,000USD | -53,081,000USD |
| Net Income From Continuing Ops | 39,206,000USD | -10,612,000USD | 63,911,000USD | -30,012,000USD | -26,370,000USD | -46,806,000USD | -67,214,000USD | -54,797,000USD |
| Ebit | 15,054,000USD | 5,407,000USD | 77,081,000USD | -16,723,000USD | -13,575,000USD | -26,120,000USD | -31,485,000USD | -23,052,000USD |
| Ebitda | 15,637,000USD | 6,004,000USD | 80,112,000USD | -13,555,000USD | -10,372,000USD | -22,860,000USD | -28,139,000USD | -19,689,000USD |
| Depreciation And Amortization | 583,000USD | 597,000USD | 3,031,000USD | 3,168,000USD | 3,203,000USD | 3,260,000USD | 3,346,000USD | 3,363,000USD |
| Reconciled Depreciation | 583,000USD | 597,000USD | 3,031,000USD | 3,168,000USD | 3,203,000USD | 3,260,000USD | 3,346,000USD | 3,363,000USD |
| Total Other Income Expense Net | 24,152,000USD | -25,010,000USD | 68,456,000USD | -13,301,000USD | -13,059,000USD | -20,910,000USD | -35,710,000USD | -24,604,000USD |
| Minority Interest | 20,000USD | 34,000USD | 3,000USD | 2,057,000USD | 1,104,000USD | 947,000USD | 828,000USD | 1,716,000USD |
| Unclassified Operating Expenses | — | -7,511,000USD | — | -26,779,000USD | -21,522,000USD | -35,866,000USD | -42,921,000USD | -36,771,000USD |
| Income Tax Expense | — | — | — | — | — | — | — | -1,716,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 114,196,000USD | 103,463,000USD | 156,314,000USD | 98,024,000USD | 295,665,000USD | 88,170,000USD | 150,048,000USD | 36,783,551USD |
| Cost Of Revenue | 80,360,000USD | 156,014,000USD | 237,680,000USD | 197,259,000USD | 182,078,000USD | 144,966,000USD | 168,339,000USD | 124,600,359USD |
| Gross Profit | 33,836,000USD | -52,551,000USD | -81,366,000USD | -99,235,000USD | 113,587,000USD | -56,796,000USD | -18,291,000USD | -87,816,808USD |
| Research Development | 79,338,000USD | 155,528,000USD | 234,569,000USD | 16,975,000USD | 178,608,000USD | 142,617,000USD | 168,339,000USD | 124,600,359USD |
| Selling General Administrative | 54,392,000USD | 71,878,000USD | 78,739,000USD | 81,007,000USD | 76,359,000USD | 59,218,000USD | 46,041,000USD | 37,339,748USD |
| Unclassified Operating Expenses | -79,338,000USD | -159,482,000USD | -235,125,000USD | -17,790,000USD | -167,127,000USD | -141,396,000USD | -162,534,000USD | -124,600,359USD |
| Total Operating Expenses | 54,392,000USD | 67,924,000USD | 78,183,000USD | 80,192,000USD | 87,840,000USD | 60,439,000USD | 51,846,000USD | 37,339,748USD |
| Operating Income | -20,556,000USD | -120,475,000USD | -159,549,000USD | -179,427,000USD | 25,747,000USD | -117,235,000USD | -70,137,000USD | -123,821,556USD |
| Interest Expense | 55,273,000USD | 117,626,000USD | 97,925,000USD | 61,863,000USD | 65,719,000USD | 61,078,000USD | 41,451,000USD | 25,272,557USD |
| Net Interest Income | -55,273,000USD | -117,626,000USD | -71,070,000USD | -61,863,000USD | -65,719,000USD | -61,078,000USD | -41,451,000USD | -25,272,557USD |
| Income Before Tax | -3,083,000USD | -232,271,000USD | -257,437,000USD | -230,656,000USD | -28,724,000USD | -182,891,000USD | -111,560,000USD | -162,044,016USD |
| Net Income | 115,000USD | -227,212,000USD | -245,761,000USD | -220,074,000USD | -23,926,000USD | -180,914,000USD | -107,657,000USD | -159,692,116USD |
| Net Income From Continuing Ops | -3,083,000USD | -232,271,000USD | -282,957,000USD | -228,719,000USD | -28,724,000USD | -182,891,000USD | -111,560,000USD | -162,044,016USD |
| Ebit | 52,190,000USD | -114,645,000USD | -159,512,000USD | -168,793,000USD | 36,995,000USD | -121,813,000USD | -70,109,000USD | -136,771,460USD |
| Ebitda | 62,189,000USD | -101,302,000USD | -145,924,000USD | -161,847,000USD | 43,783,000USD | -114,634,000USD | -63,447,000USD | -130,483,460USD |
| Depreciation And Amortization | 9,999,000USD | 13,343,000USD | 13,588,000USD | 6,946,000USD | 6,788,000USD | 7,179,000USD | 6,662,000USD | 6,288,000USD |
| Reconciled Depreciation | 9,999,000USD | 13,343,000USD | 10,276,000USD | 6,946,000USD | 6,788,000USD | 7,179,000USD | 6,662,000USD | 6,288,001USD |
| Total Other Income Expense Net | 17,473,000USD | -111,796,000USD | -97,888,000USD | -51,229,000USD | -54,471,000USD | -65,656,000USD | -41,423,000USD | -38,223,016USD |
| Minority Interest | 3,198,000USD | 5,059,000USD | 12,393,000USD | -10,582,000USD | -4,798,000USD | -7,826,000USD | -3,903,000USD | -2,078,000USD |
| Income Tax Expense | — | — | -11,676,000USD | 40,859,000USD | 65,972,000USD | 57,243,000USD | 37,576,000USD | -12,949,903USD |
| Non Operating Income Net Other | — | — | — | 12,571,000USD | 11,248,000USD | -1,858,000USD | 28,000USD | -12,949,903USD |
| Net Income Applicable To Common Shares | — | — | — | -220,286,000USD | -24,137,000USD | -181,123,000USD | -107,865,000USD | -159,899,000USD |
| Interest Income | — | — | — | — | — | — | 41,451,000USD | 25,272,560USD |
| Discontinued Operations | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 186,456,000USD | 226,798,000USD | 233,891,000USD | 185,221,000USD | 200,201,000USD | 226,271,000USD | 238,482,000USD | 292,415,000USD |
| Intangible Assets | 2,959,000USD | 3,037,000USD | 3,122,000USD | 3,206,000USD | 3,291,000USD | 3,376,000USD | 3,955,000USD | 4,136,000USD |
| Other Current Assets | 6,225,999USD | 128,607,000USD | 124,229,000USD | 3,097,000USD | 4,296,000USD | 4,730,000USD | 5,163,000USD | 5,562,000USD |
| Total Liab | 414,439,000USD | 504,659,000USD | 514,759,000USD | 521,529,000USD | 522,599,000USD | 532,695,000USD | 510,286,000USD | 513,254,000USD |
| Total Stockholder Equity | -221,221,000USD | -271,111,000USD | -274,137,000USD | -354,601,000USD | -341,848,000USD | -326,380,000USD | -292,336,000USD | -241,311,000USD |
| Other Current Liab | 37,501,000USD | 84,245,000USD | 190,009,000USD | 146,184,000USD | 138,835,000USD | 150,054,000USD | 41,862,000USD | 194,726,000USD |
| Common Stock | 385,000USD | 353,000USD | 329,000USD | 300,000USD | 266,000USD | 236,000USD | 217,000USD | 211,000USD |
| Capital Stock | 385,000USD | 353,000USD | 329,000USD | 300,000USD | 266,000USD | 236,000USD | 217,000USD | 211,000USD |
| Retained Earnings | -2,143,539,000USD | -2,182,765,000USD | -2,172,187,000USD | -2,236,101,000USD | -2,208,146,000USD | -2,182,880,000USD | -2,137,021,000USD | -2,070,635,000USD |
| Good Will | 24,092,000USD | 24,092,000USD | 24,092,000USD | 24,092,000USD | 24,092,000USD | 24,092,000USD | 24,694,000USD | 24,748,000USD |
| Cash | 34,996,000USD | 2,998,000USD | 3,458,000USD | 9,534,000USD | 18,488,000USD | 40,437,000USD | 44,784,000USD | 93,723,000USD |
| Cash And Short Term Investments | 34,996,000USD | 2,998,000USD | 3,458,000USD | 9,534,000USD | 18,488,000USD | 40,437,000USD | 44,784,000USD | 93,723,000USD |
| Total Current Assets | 95,284,000USD | 133,436,000USD | 133,950,000USD | 13,340,000USD | 23,138,000USD | 45,574,000USD | 50,154,000USD | 100,004,000USD |
| Total Current Liabilities | 249,237,000USD | 323,489,000USD | 287,132,000USD | 234,563,000USD | 208,304,000USD | 221,401,000USD | 270,644,000USD | 270,666,000USD |
| Current Deferred Revenue | 1,143,000USD | 1,143,000USD | 45,000USD | 45,000USD | 14,000USD | 31,000USD | 10,000USD | 9,000USD |
| Net Debt | 269,468,000USD | 331,901,000USD | 42,313,000USD | 81,746,000USD | 73,555,000USD | 54,433,000USD | 375,811,000USD | -12,849,000USD |
| Short Term Debt | 140,652,000USD | 155,114,000USD | 11,789,000USD | 13,983,000USD | 5,215,000USD | 9,846,000USD | 182,873,000USD | 25,088,000USD |
| Short Long Term Debt | 30,193,000USD | 44,655,000USD | 10,611,000USD | 10,721,000USD | 731,000USD | 2,698,000USD | 13,401,000USD | 13,425,000USD |
| Short Long Term Debt Total | 304,464,000USD | 334,899,000USD | 45,771,000USD | 91,280,000USD | 92,043,000USD | 94,870,000USD | 420,595,000USD | 80,874,000USD |
| Long Term Investments | 22,927,000USD | 24,277,000USD | 30,482,000USD | — | — | 0USD | — | — |
| Net Receivables | 54,062,000USD | 1,831,000USD | 6,263,000USD | 709,000USD | 354,000USD | 407,000USD | 207,000USD | 719,000USD |
| Accounts Payable | 71,084,000USD | 82,987,000USD | 85,289,000USD | 74,396,000USD | 64,240,000USD | 61,470,000USD | 45,899,000USD | 50,843,000USD |
| Property Plant Equipment Net | 22,405,000USD | 24,248,000USD | 24,014,000USD | 139,143,000USD | 144,076,000USD | 147,395,000USD | 153,084,000USD | 156,533,000USD |
| Property Plant Equipment Gross | 70,298,000USD | 70,682,000USD | 71,180,000USD | 213,925,000USD | 219,954,000USD | 219,948,000USD | 224,193,000USD | 224,670,000USD |
| Accumulated Other Comprehensive Income | -437,000USD | -439,000USD | -1,560,000USD | -1,503,999USD | -1,468,000USD | -1,398,000USD | -1,347,000USD | -1,001,000USD |
| Common Stock Shares Outstanding | 38,285,000shares | 35,320,397shares | 32,858,000shares | 28,117,000shares | 24,469,000shares | 22,506,372shares | 21,550,000shares | 21,062,000shares |
| Non Current Assets Total | 91,171,999USD | 93,362,000USD | 99,941,000USD | 171,881,000USD | 177,063,000USD | 180,697,000USD | 188,328,000USD | 192,411,000USD |
| Non Current Liabilities Total | 165,202,000USD | 181,170,000USD | 227,627,000USD | 286,966,000USD | 314,295,000USD | 311,294,000USD | 239,642,000USD | 242,588,000USD |
| Non Current Liabilities Other | 154,232,000USD | 169,919,000USD | 192,502,000USD | 209,278,000USD | 226,324,000USD | 225,127,000USD | 183,335,000USD | 185,659,000USD |
| Non Currrent Assets Other | 212,999USD | -742,000USD | 18,231,000USD | 4,521,000USD | 1,098,000USD | 5,834,000USD | 2,961,000USD | 5,501,000USD |
| Net Working Capital | -153,953,000USD | -190,053,000USD | -153,182,000USD | -221,223,000USD | -185,166,000USD | -175,827,000USD | -220,490,000USD | -170,662,000USD |
| Unclassified Non Current Assets | 18,576,000USD | 17,708,000USD | — | — | 4,506,000USD | — | 3,634,000USD | — |
| Unclassified Current Liabilities | -31,336,000USD | -44,655,000USD | -10,611,000USD | -10,766,000USD | — | -2,698,000USD | -13,401,000USD | -13,425,000USD |
| Unclassified Non Current Liabilities | 10,970,000USD | 11,251,000USD | 11,526,000USD | 54,537,000USD | 55,125,000USD | 55,694,000USD | 56,307,000USD | 56,929,000USD |
| Unclassified Equity | 1,921,985,000USD | 1,911,387,000USD | 1,898,952,000USD | 1,882,403,999USD | 1,867,234,000USD | 1,857,426,000USD | 1,845,598,000USD | 1,829,903,000USD |
| Long Term Debt | — | — | 23,599,000USD | 23,151,000USD | 32,846,000USD | 30,473,000USD | — | — |
| Short Term Investments | — | — | — | — | — | — | — | 2,141,000USD |
| Unclassified Current Assets | — | — | — | — | — | — | — | -2,141,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 226,798,000USD | 226,271,000USD | 313,913,000USD | 413,556,000USD | 465,958,000USD | 214,514,000USD | 155,335,000USD | 136,400,708USD |
| Intangible Assets | 3,037,000USD | 3,376,000USD | 4,411,000USD | 6,228,000USD | 8,488,000USD | 10,886,000USD | 10,504,000USD | 12,338,000USD |
| Other Current Assets | 128,607,000USD | 4,730,000USD | 10,470,000USD | 3,194,000USD | 3,171,000USD | 2,009,000USD | 1,015,000USD | 1,495,719USD |
| Total Liab | 504,659,000USD | 532,695,000USD | 462,295,000USD | 468,458,000USD | 418,049,000USD | 426,012,000USD | 386,672,000USD | 310,946,455USD |
| Total Stockholder Equity | -271,111,000USD | -326,380,000USD | -148,382,000USD | -54,902,000USD | 47,909,000USD | -211,498,000USD | -231,337,000USD | -174,545,747USD |
| Other Current Liab | 83,109,000USD | 150,054,000USD | 48,741,000USD | 133,226,000USD | 110,677,000USD | 92,900,000USD | 77,478,000USD | 52,478,075USD |
| Common Stock | 353,000USD | 236,000USD | 3,944,000USD | 3,056,000USD | 2,569,000USD | 1,961,000USD | 1,378,000USD | 1,199,964USD |
| Capital Stock | 353,000USD | 236,000USD | 3,944,000USD | 3,056,000USD | 2,569,000USD | 1,961,000USD | 1,378,000USD | 1,200,280USD |
| Retained Earnings | -2,182,765,000USD | -2,182,880,000USD | -1,955,668,000USD | -1,709,907,000USD | -1,489,833,000USD | -1,465,907,000USD | -1,284,993,000USD | -1,177,311,393USD |
| Good Will | 24,092,000USD | 24,092,000USD | 24,723,000USD | 25,467,000USD | 24,876,000USD | 25,452,000USD | 23,188,000USD | 22,924,870USD |
| Cash | 2,998,000USD | 40,437,000USD | 76,110,000USD | 178,674,000USD | 291,931,000USD | 99,871,000USD | 61,808,000USD | 53,053,531USD |
| Cash And Short Term Investments | 2,998,000USD | 40,437,000USD | 76,110,000USD | 193,358,000USD | 306,923,000USD | 99,871,000USD | 61,808,000USD | 53,053,531USD |
| Total Current Assets | 133,436,000USD | 45,574,000USD | 112,416,000USD | 213,122,000USD | 331,974,000USD | 113,783,000USD | 86,536,000USD | 74,807,680USD |
| Total Current Liabilities | 323,489,000USD | 221,401,000USD | 255,897,000USD | 188,952,000USD | 156,943,000USD | 129,884,000USD | 122,209,000USD | 68,062,216USD |
| Current Deferred Revenue | 1,143,000USD | 31,000USD | 18,000USD | 12,269,000USD | 12,425,000USD | 17,186,000USD | 29,174,000USD | 1,814,146USD |
| Net Debt | 331,901,000USD | 54,433,000USD | 274,136,000USD | -100,246,000USD | -233,644,000USD | -44,144,000USD | -38,415,000USD | -39,695,923USD |
| Short Term Debt | 156,250,000USD | 9,846,000USD | 145,692,000USD | 2,518,000USD | 3,355,000USD | 2,783,000USD | 1,993,000USD | 146,061USD |
| Short Long Term Debt | 44,655,000USD | 2,698,000USD | 146,000USD | 575,000USD | 728,000USD | 833,000USD | 646,000USD | 146,061USD |
| Short Long Term Debt Total | 334,899,000USD | 94,870,000USD | 350,246,000USD | 78,428,000USD | 58,287,000USD | 55,727,000USD | 23,393,000USD | 13,357,608USD |
| Long Term Investments | 24,277,000USD | 0USD | — | — | — | — | — | 0USD |
| Net Receivables | 1,831,000USD | 407,000USD | 25,836,000USD | 2,741,000USD | 1,518,000USD | 1,157,000USD | 16,293,000USD | 938,141USD |
| Accounts Payable | 82,987,000USD | 61,470,000USD | 61,446,000USD | 40,939,000USD | 30,486,000USD | 17,015,000USD | 13,564,000USD | 13,623,934USD |
| Property Plant Equipment Net | 24,248,000USD | 147,395,000USD | 163,027,000USD | 164,286,000USD | 91,083,000USD | 60,270,000USD | 33,690,000USD | 25,116,000USD |
| Property Plant Equipment Gross | 70,682,000USD | 219,948,000USD | 224,970,000USD | 218,361,000USD | 141,622,000USD | 60,270,000USD | 26,326,000USD | 25,115,578USD |
| Accumulated Other Comprehensive Income | -439,000USD | -1,398,000USD | -955,000USD | 915,000USD | 1,492,000USD | 2,772,000USD | -1,324,000USD | -1,539,367USD |
| Common Stock Shares Outstanding | 29,734,000shares | 21,473,000shares | 17,894,450shares | 14,087,150shares | 11,445,950shares | 8,625,200shares | 6,749,100shares | 5,538,600shares |
| Non Current Assets Total | 93,362,000USD | 180,697,000USD | 201,497,000USD | 200,434,000USD | 133,984,000USD | 100,731,000USD | 68,799,000USD | 61,593,264USD |
| Non Current Liabilities Total | 181,170,000USD | 311,294,000USD | 206,398,000USD | 279,506,000USD | 261,106,000USD | 296,128,000USD | 264,463,000USD | 242,884,239USD |
| Non Current Liabilities Other | 169,919,000USD | 225,127,000USD | 129,976,000USD | 14,700,000USD | 3,266,000USD | 187,985,000USD | 13,033,000USD | 188,628,460USD |
| Non Currrent Assets Other | -742,000USD | 5,834,000USD | 5,667,000USD | 4,453,000USD | 9,537,000USD | 4,123,000USD | 1,417,000USD | 1,214,394USD |
| Net Working Capital | -190,053,000USD | -175,827,000USD | -143,481,000USD | 24,170,000USD | 175,031,000USD | -16,101,000USD | -35,673,000USD | 6,745,464USD |
| Unclassified Non Current Assets | 17,708,000USD | — | 3,669,000USD | -4,453,000USD | -9,537,000USD | -37,603,000USD | -1,417,000USD | — |
| Unclassified Current Liabilities | -44,655,000USD | -2,698,000USD | — | — | — | — | — | — |
| Unclassified Non Current Liabilities | 11,251,000USD | 55,694,000USD | 63,654,000USD | 60,896,000USD | 39,161,000USD | -126,937,000USD | 21,904,000USD | -148,748,768USD |
| Unclassified Equity | 1,911,387,000USD | 1,857,426,000USD | 1,800,353,000USD | 1,647,978,000USD | 1,531,112,000USD | 1,247,715,000USD | 1,052,224,000USD | 1,001,904,769USD |
| Long Term Debt | — | 30,473,000USD | 12,768,000USD | 12,584,000USD | 12,823,000USD | 18,879,000USD | 13,380,000USD | 13,211,547USD |
| Short Term Investments | — | — | 447,000USD | 14,684,000USD | 14,992,000USD | 0USD | — | 0USD |
| Inventory | — | — | 1USD | 13,829,000USD | 20,362,000USD | 10,746,000USD | 7,420,000USD | 55,491USD |
| Other Liab | — | — | — | 191,326,000USD | 205,856,000USD | 216,201,000USD | 216,146,000USD | 189,793,000USD |
| Other Assets | — | — | — | 4,453,000USD | 9,537,000USD | 37,603,000USD | 1,417,000USD | -236USD |
| Net Tangible Assets | — | — | — | 159,249,000USD | 1,076,000USD | -240,010,000USD | -20,998,000USD | -207,730,000USD |
| Deferred Long Term Liab | — | — | — | — | — | — | — | 0USD |
| Additional Paid In Capital | — | — | — | — | — | — | — | 0USD |
| Treasury Stock | — | — | — | — | — | — | — | 0USD |
| Unclassified Current Assets | — | — | — | — | — | — | — | 19,264,798USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 39,226,000USD | -10,612,000USD | 63,911,000USD | -30,012,000USD | -26,370,000USD | -45,859,000USD | -67,214,000USD | -54,797,000USD |
| Depreciation | 583,000USD | 597,000USD | 3,031,000USD | 3,168,000USD | 3,203,000USD | 3,260,000USD | 3,346,000USD | 3,363,000USD |
| Stock Based Compensation | 1,098,000USD | 3,461,000USD | 3,242,000USD | 3,585,000USD | 3,482,000USD | 4,674,000USD | 4,531,000USD | 4,033,000USD |
| Other Non Cash Items | -51,959,000USD | -6,254,000USD | -97,439,000USD | -10,669,000USD | -10,853,000USD | -153,000USD | 7,995,000USD | 3,542,000USD |
| Change To Account Receivables | -4,731,000USD | -1,679,000USD | 183,000USD | -340,000USD | 108,000USD | -269,000USD | 492,000USD | -220,000USD |
| Change In Working Capital | -23,800,000USD | -3,810,000USD | 12,518,000USD | 13,706,000USD | 4,920,000USD | 14,100,000USD | -1,950,000USD | 5,679,000USD |
| Total Cash From Operating Activities | -35,950,000USD | -16,618,000USD | -14,737,000USD | -20,222,000USD | -25,618,000USD | -28,652,000USD | -53,292,000USD | -38,180,000USD |
| Capital Expenditures | 0USD | -582,000USD | -6,000USD | -1,000USD | -5,000USD | -73,000USD | -7,000USD | -461,000USD |
| Free Cash Flow | -35,950,000USD | -16,618,000USD | -14,737,000USD | -20,223,000USD | -25,623,000USD | -28,725,000USD | -53,299,000USD | -38,641,000USD |
| Investments | 7,000USD | 779,000USD | 76,000USD | 281,000USD | 57,000USD | -21,000USD | 56,000USD | -237,000USD |
| Total Cashflows From Investing Activities | 68,952,000USD | 780,000USD | 76,000USD | 281,000USD | 57,000USD | -21,000USD | 56,000USD | -237,000USD |
| Net Borrowings | -8,440,000USD | 7,008,000USD | -678,000USD | -1,210,000USD | -2,771,000USD | 17,285,000USD | -2,660,000USD | — |
| Total Cash From Financing Activities | -993,000USD | 15,374,000USD | 6,683,000USD | 10,942,000USD | 3,594,000USD | 24,370,000USD | 4,557,000USD | 79,083,000USD |
| Sale Purchase Of Stock | -27,000USD | -87,000USD | 87,000USD | -65,000USD | -22,000USD | 0USD | 0USD | 0USD |
| Issuance Of Capital Stock | 7,419,000USD | 8,611,000USD | 8,965,000USD | 12,217,000USD | 6,343,000USD | 7,086,000USD | 6,776,000USD | 1,990,000USD |
| Change In Cash | 31,998,000USD | -460,000USD | -7,998,000USD | -8,954,000USD | -21,949,000USD | -4,347,000USD | -48,939,000USD | 40,832,000USD |
| Begin Period Cash Flow | 2,998,000USD | 5,170,000USD | 13,168,000USD | 22,122,000USD | 44,071,000USD | 44,784,000USD | 97,357,000USD | 56,525,000USD |
| End Period Cash Flow | 34,996,000USD | 4,710,000USD | 5,170,000USD | 13,168,000USD | 22,122,000USD | 40,437,000USD | 48,418,000USD | 97,357,000USD |
| Other Cashflows From Investing Activities | 68,945,000USD | 1,000USD | 76,000USD | 282,000USD | -5,000USD | — | 24,000USD | — |
| Other Cashflows From Financing Activities | -993,000USD | -292,000USD | -1,604,000USD | 10,942,000USD | 44,000USD | -73,851,000USD | 441,000USD | 73,885,000USD |
| Unclassified Operating Cash Flow | -1,098,000USD | — | — | — | — | -4,674,000USD | — | — |
| Unclassified Financing Cash Flow | 8,467,000USD | 8,745,000USD | 8,878,000USD | 1,275,000USD | 6,343,000USD | 80,936,000USD | 6,776,000USD | 5,198,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -232,271,000USD | -232,271,000USD | -257,437,000USD | -230,656,000USD | -28,724,000USD | -182,891,000USD | -111,560,000USD | -162,044,016USD |
| Depreciation | 13,343,000USD | 13,343,000USD | 13,588,000USD | 6,946,000USD | 6,788,000USD | 7,179,000USD | 6,662,000USD | 6,288,000USD |
| Stock Based Compensation | 17,390,000USD | 17,390,000USD | 22,869,000USD | 18,337,000USD | 19,577,000USD | 10,417,000USD | 9,892,000USD | 7,625,128USD |
| Other Non Cash Items | 15,889,000USD | 10,619,000USD | -13,978,000USD | 5,916,000USD | 31,745,000USD | 17,245,000USD | 17,582,000USD | 5,954,685USD |
| Change To Account Receivables | -1,728,000USD | 25,344,000USD | -23,461,000USD | 122,000USD | -394,000USD | 16,187,000USD | -15,355,000USD | 196,352USD |
| Change In Working Capital | 27,334,000USD | 32,604,000USD | 10,756,000USD | 24,084,000USD | -9,743,000USD | 8,954,000USD | 58,684,000USD | 170,051USD |
| Total Cash From Operating Activities | -158,315,000USD | -158,315,000USD | -224,202,000USD | -175,373,000USD | 10,145,000USD | -139,096,000USD | -18,682,000USD | -131,094,517USD |
| Capital Expenditures | -576,000USD | -576,000USD | -9,954,000USD | -53,062,000USD | -33,814,000USD | -3,466,000USD | -4,657,000USD | -3,597,107USD |
| Free Cash Flow | -158,891,000USD | -158,891,000USD | -234,156,000USD | -228,435,000USD | -23,669,000USD | -142,562,000USD | -23,339,000USD | -134,691,624USD |
| Investments | 841,000USD | 27,000USD | 3,400,000USD | 371,000USD | -14,992,000USD | -4,441,000USD | -4,657,000USD | -3,590,920USD |
| Total Cashflows From Investing Activities | 27,000USD | 27,000USD | 3,400,000USD | -33,610,000USD | -43,150,000USD | -4,441,000USD | -4,657,000USD | -3,590,920USD |
| Net Borrowings | 2,349,000USD | 9,519,000USD | -8,926,000USD | -490,000USD | -1,317,000USD | 2,965,000USD | -320,000USD | -162,130,628USD |
| Total Cash From Financing Activities | 122,840,000USD | 122,840,000USD | 119,866,000USD | 95,830,000USD | 225,264,000USD | 183,855,000USD | 31,323,000USD | 128,284,917USD |
| Sale Purchase Of Stock | -87,000USD | 0USD | -5,172,000USD | -3,789,000USD | -1,654,000USD | 176,421,000USD | 30,000,000USD | 86,031,539USD |
| Issuance Of Capital Stock | 36,136,000USD | 38,823,000USD | 133,157,000USD | 99,211,000USD | 220,645,000USD | 176,421,000USD | 30,000,000USD | 84,797,639USD |
| Change In Cash | -35,708,000USD | -35,708,000USD | -101,564,000USD | -113,257,000USD | 192,095,000USD | 40,697,000USD | 8,754,000USD | -7,133,086USD |
| Begin Period Cash Flow | 79,779,000USD | 79,779,000USD | 181,343,000USD | 294,600,000USD | 102,505,000USD | 61,808,000USD | 53,054,000USD | 60,186,617USD |
| End Period Cash Flow | 44,071,000USD | 44,071,000USD | 79,779,000USD | 181,343,000USD | 294,600,000USD | 102,505,000USD | 61,808,000USD | 53,053,531USD |
| Other Cashflows From Investing Activities | 24,000USD | 24,000USD | 3,363,000USD | 21,998,000USD | 5,656,000USD | -975,000USD | — | 6,187USD |
| Other Cashflows From Financing Activities | 84,273,000USD | 74,498,000USD | 807,000USD | 898,000USD | 16,722,000USD | 4,469,000USD | 1,643,000USD | 244,264,089USD |
| Unclassified Financing Cash Flow | 36,305,000USD | 38,823,000USD | 133,157,000USD | 99,211,000USD | 220,645,000USD | — | — | -39,880,083USD |
| Unclassified Investing Cash Flow | — | — | 6,591,000USD | -2,917,000USD | — | 4,441,000USD | 4,657,000USD | 3,590,920USD |
| Change To Liabilities | — | — | — | 8,528,000USD | -11,008,000USD | -8,697,000USD | 6,863,000USD | 8,670,270USD |
| Cash And Cash Equivalents Changes | — | — | — | -113,153,000USD | 192,259,000USD | 40,318,000USD | 7,984,000USD | -6,400,520USD |
| Change To Inventory | — | — | — | — | -6,191,000USD | 3,639,000USD | 55,000USD | 24,000USD |
| Dividends Paid | — | — | — | — | -9,132,000USD | — | — | 0USD |
| Unclassified Operating Cash Flow | — | — | — | — | -9,498,000USD | — | — | 10,911,635USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| FY 2025Yearly · 2025-12-31 | Geography | International | 1,036,000 | USD | 0001193125-26-108632 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 113,160,000 | USD | 0001193125-26-108632 |
| Q2 2025Quarterly · 2025-06-30 | Geography | International | 526,000 | USD | 0000950170-25-106633 |
| Q2 2025Quarterly · 2025-06-30 | Geography | United States | 25,165,000 | USD | 0000950170-25-106633 |
| Q1 2025Quarterly · 2025-03-31 | Geography | International | 510,000 | USD | 0001193125-26-217082 |
| Q1 2025Quarterly · 2025-03-31 | Geography | United States | 23,556,000 | USD | 0001193125-26-217082 |
| FY 2024Yearly · 2024-12-31 | Geography | International | 2,003,000 | USD | 0001193125-26-108632 |
| FY 2024Yearly · 2024-12-31 | Geography | United States | 101,460,000 | USD | 0001193125-26-108632 |
| Q4 2024Quarterly · 2024-12-31 | Geography | International | 651,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | United States | 26,186,000 | USD | Legacy provider |
| Q3 2024Quarterly · 2024-09-30 | Geography | International | 454,000 | USD | 0001193125-25-274554 |
| Q3 2024Quarterly · 2024-09-30 | Geography | United States | 24,658,000 | USD | 0001193125-25-274554 |
| Q2 2024Quarterly · 2024-06-30 | Geography | International | 660,000 | USD | 0000950170-25-106633 |
| Q2 2024Quarterly · 2024-06-30 | Geography | United States | 22,849,000 | USD | 0000950170-25-106633 |
| Q1 2024Quarterly · 2024-03-31 | Geography | International | 238,000 | USD | 0000950170-25-069396 |
| Q1 2024Quarterly · 2024-03-31 | Geography | United States | 27,767,000 | USD | 0000950170-25-069396 |
| FY 2023Yearly · 2023-12-31 | Geography | International | 2,978,000 | USD | 0001193125-26-108632 |
| FY 2023Yearly · 2023-12-31 | Geography | United States | 153,336,000 | USD | 0001193125-26-108632 |
| Q4 2023Quarterly · 2023-12-31 | Geography | International | 515,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Geography | United States | 83,287,000 | USD | Legacy provider |
| Q3 2023Quarterly · 2023-09-30 | Geography | International | 540,000 | USD | 0000950170-24-125608 |
| Q3 2023Quarterly · 2023-09-30 | Geography | United States | 23,774,000 | USD | 0000950170-24-125608 |
| Q3 2021Quarterly · 2021-09-30 | Product | Clinical Product Revenue | 587,000 | USD | 0001564590-21-055721 |
| Q3 2021Quarterly · 2021-09-30 | Product | Non Cash Royalty Revenue Related To The Sale Of Future Royalties | 12,593,000 | USD | 0001564590-21-055721 |
| Q3 2021Quarterly · 2021-09-30 | Product | Other | 1,375,000 | USD | 0001564590-21-055721 |
| Q3 2021Quarterly · 2021-09-30 | Product | Recognition Of Deferred Revenue | 18,189,000 | USD | 0001564590-21-055721 |
| Q3 2021Quarterly · 2021-09-30 | Product | Research And Development Revenue — License And Collaboration Milestones | 220,000,000 | USD | 0001564590-21-055721 |
| Q3 2021Quarterly · 2021-09-30 | Product | Research And Development Services | 210,000 | USD | 0001564590-21-055721 |
| Q3 2021Quarterly · 2021-09-30 | Product | Revenue | 1,375,000 | USD | 0001564590-21-055721 |
| FY 2019Yearly · 2019-12-31 | Geography | International | 690,000 | USD | 0001564590-22-007867 |
| FY 2019Yearly · 2019-12-31 | Geography | Rest of World | 690,000 | USD | 0001564590-22-007867 |
| FY 2019Yearly · 2019-12-31 | Geography | United States | 149,358,000 | USD | 0001564590-22-007867 |
| FY 2018Yearly · 2018-12-31 | Geography | Europe | 4,000,000 | USD | 0001564590-20-011221 |
| FY 2018Yearly · 2018-12-31 | Geography | United States | 32,784,000 | USD | 0001564590-20-011221 |
| Q3 2018Quarterly · 2018-09-30 | Product | License And Service | 0 | USD | 0001564590-18-028042 |
| Q3 2018Quarterly · 2018-09-30 | Product | Non Cash Royalty Revenue Related To The Sale Of Future Royalties | 6,526,291 | USD | 0001564590-18-028042 |
| Q3 2018Quarterly · 2018-09-30 | Product | Recognition Of Deferred Revenue | 262,000 | USD | 0001564590-18-028042 |
| Q3 2018Quarterly · 2018-09-30 | Product | Research And Development Revenue — License And Collaboration Milestones | 5,000,000 | USD | 0001564590-18-028042 |
| Q3 2018Quarterly · 2018-09-30 | Product | Research And Development Services | 1,014,000 | USD | 0001564590-18-028042 |
| FY 2017Yearly · 2017-12-31 | Geography | Europe | 3,994,000 | USD | 0001564590-20-011221 |
| FY 2017Yearly · 2017-12-31 | Geography | United States | 38,883,000 | USD | 0001564590-20-011221 |
| FY 2017Yearly · 2017-12-31 | Product | Grant | 168,000 | USD | 0001564590-20-011221 |
| FY 2017Yearly · 2017-12-31 | Product | Product And Service Other | 168,000 | USD | 0001564590-20-011221 |
| FY 2017Yearly · 2017-12-31 | Product | Recognition Of Deferred Research And Development Revenue | 3,100,000 | USD | 0001564590-20-011221 |
| FY 2017Yearly · 2017-12-31 | Product | Research And Development Revenue — License And Collaboration Milestones | 24,994,000 | USD | 0001564590-20-011221 |
| FY 2017Yearly · 2017-12-31 | Product | Research And Development Services | 14,615,000 | USD | 0001564590-20-011221 |
| Q3 2017Quarterly · 2017-09-30 | Product | License And Service | 0 | USD | 0001564590-18-028042 |
| Q3 2017Quarterly · 2017-09-30 | Product | Research And Development Revenue | 3,359,399 | USD | 0001564590-18-028042 |
| Q2 2017Quarterly · 2017-06-30 | Product | License And Service | 0 | USD | 0001564590-18-021059 |
| Q2 2017Quarterly · 2017-06-30 | Product | Research And Development Revenue | 4,207,573 | USD | 0001564590-18-021059 |
| FY 2016Yearly · 2016-12-31 | Geography | Europe | 2,241,000 | USD | 0001564590-19-008311 |
| FY 2016Yearly · 2016-12-31 | Geography | United States | 20,332,000 | USD | 0001564590-19-008311 |
| FY 2015Yearly · 2015-12-31 | Geography | Europe | 1,149,000 | USD | 0001564590-18-006093 |
| FY 2015Yearly · 2015-12-31 | Geography | United States | 23,668,000 | USD | 0001564590-18-006093 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.